Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3853)
All Articles published online
|
Nov 28, 2006 (publication date) through Feb 14, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Romero-Gómez M. Insulin resistance and hepatitis C. World J Gastroenterol 2006; 12(44): 7075-7080 [PMID: 17131467 DOI: 10.3748/wjg.v12.i44.7075] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i44/7075.htm |
| Number | Citing Articles |
| 1 |
Hans L Tillmann. Does the presence of hepatic steatosis influence the efficacy of antiviral treatment in patients with hepatitis C?. Nature Clinical Practice Gastroenterology & Hepatology 2007; 4(10): 548 doi: 10.1038/ncpgasthep0930
|
| 2 |
Maribel Rodríguez–Torres. Latinos and Chronic Hepatitis C: A Singular Population. Clinical Gastroenterology and Hepatology 2008; 6(5): 484 doi: 10.1016/j.cgh.2008.02.036
|
| 3 |
Sumanta Ray, Ujjwal Maulik, Anirban Mukhopadhyay. A review of computational approaches for analysis of hepatitis C virus-mediated liver diseases. Briefings in Functional Genomics 2018; 17(6): 428 doi: 10.1093/bfgp/elx040
|
| 4 |
Rami Moucari, Tarik Asselah, Dominique Cazals–Hatem, Hélène Voitot, Nathalie Boyer, Marie–Pierre Ripault, Rodolphe Sobesky, Michèle Martinot–Peignoux, Sarah Maylin, Marie–Hélène Nicolas–Chanoine, Valérie Paradis, Michel Vidaud, Dominique Valla, Pierre Bedossa, Patrick Marcellin. Insulin Resistance in Chronic Hepatitis C: Association With Genotypes 1 and 4, Serum HCV RNA Level, and Liver Fibrosis. Gastroenterology 2008; 134(2): 416 doi: 10.1053/j.gastro.2007.11.010
|
| 5 |
Juber Herrera-Uribe, Orla Convery, Daniah ALmohammadi, Fabienne Ingrid Weinberg, Nigel J. Stevenson. The Neglected Suppressor of Cytokine Signalling (SOCS): SOCS4-7. Inflammation 2024; doi: 10.1007/s10753-024-02163-7
|
| 6 |
P. HALFON, G. PÉNARANDA, F. CARRAT, P. BEDOSSA, M. BOURLIÈRE, D. OUZAN, C. RENOU, A. TRAN, E. ROSENTHAL, C. WARTELLE, P. DELASALLE, P. CACOUB. Influence of insulin resistance on hepatic fibrosis and steatosis in hepatitis C virus (HCV) mono‐infected compared with HIV–HCV co‐infected patients. Alimentary Pharmacology & Therapeutics 2009; 30(1): 61 doi: 10.1111/j.1365-2036.2009.03995.x
|
| 7 |
Hasan S. Zeki Aksu, Behice Kurtaran, Yusuf Onlen, Mustafa Namiduru, Ahmet C. Inkaya, Ozlem Kandemir, Figen Doran, Omer Evirgen, Yesim Alpay, Suda K. Tekin, Yesim Kurekci, Berrin Unlu, Durdane Midikli, Yeşim Taşova, Fatih Ozdener, Seda Erdogan. Association of insulin resistance, viral load, and adipokine levels with liver histology in patients with chronic hepatitis C. European Journal of Gastroenterology & Hepatology 2012; 24(12): 1393 doi: 10.1097/MEG.0b013e3283585863
|
| 8 |
Dana Crisan, Mircea Dan Grigorescu, Corina Radu, Alina Suciu, Mircea Grigorescu. Interferon-γ-inducible protein-10 in chronic hepatitis C. Indian Journal of Medical Research 2017; 145(4): 543 doi: 10.4103/ijmr.IJMR_1410_14
|
| 9 |
Mahmoud Aboelneen Khattab. Targeting host factors: A novel rationale for the management of hepatitis C virus. World Journal of Gastroenterology 2009; 15(28): 3472-3479 doi: 10.3748/wjg.15.3472
|
| 10 |
Cheng‐Hao Tseng, Yao‐Chun Hsu, Chi‐Yang Chang, Chih‐Wen Lin, Jaw‐Town Lin, Lein‐Ray Mo. Change in insulin resistance according to virological response during antiviral treatment for hepatitis C virus infection. Advances in Digestive Medicine 2016; 3(2): 43 doi: 10.1016/j.aidm.2014.12.003
|
| 11 |
Jae Young Jang, Raymond T. Chung. New treatments for chronic hepatitis C. The Korean Journal of Hepatology 2010; 16(3): 263 doi: 10.3350/kjhep.2010.16.3.263
|
| 12 |
M Cesari, I Caramma, S Antinori, F Adorni, M Galli, L Milazzo. Impact of hyperglycaemia and cholesterol levels on the outcome of hepatitis C virus (HCV) treatment in HIV/HCV‐coinfected patients. HIV Medicine 2009; 10(9): 580 doi: 10.1111/j.1468-1293.2009.00729.x
|
| 13 |
Marcela Pezzoto LAURITO, Giovanni Faria SILVA, Hugo CHEINQUER, Rajani SHARMA, Elizabeth VERNA, Edison Roberto PARISE. DOES INSULIN RESISTANCE IMPAIR THE VIROLOGICAL RESPONSE TO PEGINTERFERON/RIBAVIRIN IN CHRONIC HEPATITIS C GENOTYPE 3 PATIENTS?. Arquivos de Gastroenterologia 2018; 55(2): 179 doi: 10.1590/s0004-2803.201800000-32
|
| 14 |
Marco Arrese, Arnoldo Riquelme, Alejandro Soza. Insulin resistance, hepatic steatosis and hepatitis C: A complex relationship with relevant clinical implications. Annals of Hepatology 2010; 9: S112 doi: 10.1016/S1665-2681(19)31735-1
|
| 15 |
János Fehér, Gabriella Lengyel. Silymarin in the treatment of chronic liver diseases: Past and future. Clinical and Experimental Medical Journal 2009; 3(3): 403 doi: 10.1556/CEMED.3.2009.28519
|
| 16 |
Annalisa Cespiati, Salvatore Petta, Rosa Lombardi, Vito Di Marco, Vincenza Calvaruso, Cristina Bertelli, Giuseppina Pisano, Erika Fatta, Giordano Sigon, Federica Iuculano, Luciano Crapanzano, Gerlando Gibilaro, Paolo Francione, Antonio Craxì, Silvia Fargion, Anna Ludovica Fracanzani. Metabolic comorbidities and male sex influence steatosis in chronic hepatitis C after viral eradication by direct-acting antiviral therapy (DAAs): Evaluation by the controlled attenuation parameter (CAP). Digestive and Liver Disease 2021; 53(10): 1301 doi: 10.1016/j.dld.2020.11.001
|
| 17 |
Ines Bilić-Ćurčić, Hrvoje Roguljić, Marul Ivandić, Aleksandar Včev, Robert Smolić, Martina Smolić. Update on Hepatitis C. 2017; doi: 10.5772/intechopen.70721
|
| 18 |
M.A. Shawky, A.Q. Mohammed, A.M. Hassan, B.H. Ali, H.M. Moustafa. Insulin resistance in nondiabetic Egyptian patients with chronic hepatitis C virus. Revista de Gastroenterología de México (English Edition) 2020; 85(2): 173 doi: 10.1016/j.rgmxen.2019.05.007
|
| 19 |
Carmelo García-Monzón, Oreste Lo Iacono, Rafael Mayoral, Águeda González-Rodríguez, María E. Miquilena-Colina, Tamara Lozano-Rodríguez, Leonor García-Pozo, Javier Vargas-Castrillón, Marta Casado, Lisardo Boscá, Ángela M. Valverde, Paloma Martín-Sanz. Hepatic insulin resistance is associated with increased apoptosis and fibrogenesis in nonalcoholic steatohepatitis and chronic hepatitis C. Journal of Hepatology 2011; 54(1): 142 doi: 10.1016/j.jhep.2010.06.021
|
| 20 |
Diego García-Compeán, Joel O. Jáquez-Quintana, Fernando J. Lavalle-González, José A. González-González, Héctor J. Maldonado-Garza, Jesús Z. Villarreal-Pérez. Plasma cytokine levels imbalance in cirrhotic patients with impaired glucose tolerance and diabetes mellitus. A prospective study. Annals of Hepatology 2014; 13(4): 403 doi: 10.1016/S1665-2681(19)30847-6
|
| 21 |
Mohammed Eslam, Reyes Aparcero, Manuel Romero Gomez. Changes in insulin sensitivity and body weight during and after peginterferon and ribavirin therapy for hepatitis C. Annals of Hepatology 2011; 10(2): 241 doi: 10.1016/S1665-2681(19)31578-9
|
| 22 |
Fahed Parvaiz, Sobia Manzoor, Huma Tariq, Farakh Javed, Kaneez Fatima, Ishtiaq Qadri. Hepatitis C Virus Infection: Molecular Pathways to Insulin resistance. Virology Journal 2011; 8(1) doi: 10.1186/1743-422X-8-474
|
| 23 |
Aldona Kasprzak, Agnieszka Adamek. Role of hepatitis C virus proteins (C, NS3, NS5A) in hepatic oncogenesis. Hepatology Research 2008; 38(1): 1 doi: 10.1111/j.1872-034X.2007.00261.x
|
| 24 |
Ghada F. Helaly, Nabila G. Hussein, Wael Refai, Mervat Ibrahim. Relation of serum insulin-like growth factor-1 (IGF-1) levels with hepatitis C virus infection and insulin resistance. Translational Research 2011; 158(3): 155 doi: 10.1016/j.trsl.2011.04.005
|
| 25 |
Abdel-Rahman El-Zayadi. Hepatitis C comorbidities affecting the course and response to therapy. World Journal of Gastroenterology 2009; 15(40): 4993-4999 doi: 10.3748/wjg.15.4993
|
| 26 |
Taher I. El Serafi, Mohamed M. Awad, Loaa A. Tag Eldeen, Ahmed T. El Serafi, Marwa Husin. Effect of interleukin-6 and insulin resistance on early virological response of Egyptian chronic hepatitis C patients to combined pegylated interferon plus ribavirin therapy. Egyptian Liver Journal 2013; 3(2): 21 doi: 10.1097/01.ELX.0000427103.05494.6c
|
| 27 |
Spilios Manolakopoulos, Sotirios Bethanis, Charis Liapi, Fotini Stripeli, Pantelis Sklavos, Alexandra Margeli, Aggeliki Christidou, Aggeliki Katsanika, Evangellos Vogiatzakis, Dimitrios Tzourmakliotis, Stamatios Theocharis. An assessment of serum leptin levels in patients with chronic viral hepatitis: a prospective study. BMC Gastroenterology 2007; 7(1) doi: 10.1186/1471-230X-7-17
|
| 28 |
Jamak Modaresi Esfeh, Kianoush Ansari-Gilani. Steatosis and hepatitis C. Gastroenterology Report 2015; : gov040 doi: 10.1093/gastro/gov040
|
| 29 |
Sabrina Corbetta, Alessandro Redaelli, Massimo Pozzi, Giorgio Bovo, Laura Ratti, Elena Redaelli, Caterina Pellegrini, Paolo Beck-Peccoz, Anna Spada. Fibrosis is associated with adiponectin resistance in chronic hepatitis C virus infection. European Journal of Clinical Investigation 2011; 41(8): 898 doi: 10.1111/j.1365-2362.2011.02498.x
|
| 30 |
Susan L. Uprichard. Hepatitis C virus experimental model systems and antiviral drug research. Virologica Sinica 2010; 25(4): 227 doi: 10.1007/s12250-010-3134-0
|
| 31 |
Hari S. Conjeevaram, Abdus S. Wahed, Nezam Afdhal, Charles D. Howell, James E. Everhart, Jay H. Hoofnagle. Changes in Insulin Sensitivity and Body Weight During and After Peginterferon and Ribavirin Therapy for Hepatitis C. Gastroenterology 2011; 140(2): 469 doi: 10.1053/j.gastro.2010.11.002
|
| 32 |
Anne-Claire Desbois, Patrice Cacoub. Diabetes mellitus, insulin resistance and hepatitis C virus infection: A contemporary review. World Journal of Gastroenterology 2017; 23(9): 1697-1711 doi: 10.3748/wjg.v23.i9.1697
|
| 33 |
Michele Colaci, Lorenzo Malatino, Alessandro Antonelli, Poupak Fallahi, Dilia Giuggioli, Clodoveo Ferri. Endocrine disorders associated with hepatitis C virus chronic infection. Reviews in Endocrine and Metabolic Disorders 2018; 19(4): 397 doi: 10.1007/s11154-018-9475-y
|
| 34 |
M.A. Shawky, A.Q. Mohammed, A.M. Hassan, B.H. Ali, H.M. Moustafa. Resistencia a la insulina en pacientes egipcios no diabéticos infectados con el virus de hepatitis C crónica. Revista de Gastroenterología de México 2020; 85(2): 173 doi: 10.1016/j.rgmx.2019.05.005
|
| 35 |
Ekram W. Abd El-Wahab, Hesham AK. Ayoub, Aziza A. Shorbila, Ashraf Mikheal, Mohamed Fadl, Amira M. Kotkat. Noninvasive biomarkers predict improvement in liver fibrosis after successful generic DAAs based therapy of chronic hepatitis C in Egypt. Clinical Epidemiology and Global Health 2020; 8(4): 1177 doi: 10.1016/j.cegh.2020.04.011
|
| 36 |
Hisamitsu Miyaaki, Tatsuki Ichikawa, Kazuhiko Nakao, Toshihisa Matsuzaki, Toru Muraoka, Takuya Honda, Shigeyuki Takeshita, Hidetaka Shibata, Eisuke Ozawa, Motohisa Akiyama, Satoshi Miuma, Katsumi Eguchi. Predictive value of suppressor of cytokine signal 3 (SOCS3) in the outcome of interferon therapy in chronic hepatitis C. Hepatology Research 2009; 39(9): 850 doi: 10.1111/j.1872-034X.2009.00529.x
|
| 37 |
Hanadi Qashqari, Amany Al-Mars, Adeel Chaudhary, Adel Abuzenadah, Ghazi Damanhouri, Mohammed Alqahtani, Maged Mahmoud, Maysaa El Sayed Zaki, Kaneez Fatima, Ishtiaq Qadri. Understanding the molecular mechanism(s) of hepatitis C virus (HCV) induced interferon resistance. Infection, Genetics and Evolution 2013; 19: 113 doi: 10.1016/j.meegid.2013.06.025
|
| 38 |
Marcos V. Carneiro, Fernanda F. Souza, Andreza C. Teixeira, José F.C. Figueiredo, Marcia G. Villanova, Marie Secaf, Afonso Passos, Leandra N.Z. Ramalho, Fabiana P. Carneiro, Sérgio Zucoloto, Ana L. Candolo Martinelli. The H63D genetic variant of the HFE gene is independently associated with the virological response to interferon and ribavirin therapy in chronic hepatitis C. European Journal of Gastroenterology & Hepatology 2010; 22(10): 1204 doi: 10.1097/MEG.0b013e32833bec1e
|
| 39 |
Peginterferon and Ribavirin for Hepatitis C. New England Journal of Medicine 2007; 356(12): 1269 doi: 10.1056/NEJMc063729
|
| 40 |
Amal A Mohamed, Samah A Loutfy, James D Craik, Abdel Gawad M Hashem, Ibrahem Siam. Chronic hepatitis c genotype-4 infection: role of insulin resistance in hepatocellular carcinoma. Virology Journal 2011; 8(1) doi: 10.1186/1743-422X-8-496
|
| 41 |
D. Crisan, C. Radu, A. Suciu, N. Leach, H. Stefanescu, L. Avram, N. Crisan, M. Grigorescu. Hepatitis C in nonobese nondiabetic patients: Insulin resistance and the metabolic syndrome make a difference. Journal of Viral Hepatitis 2017; 24(1): 86 doi: 10.1111/jvh.12610
|
| 42 |
János Fehér, Gabriella Lengyel. Silymarin in the treatment of chronic liver diseases: past and future. Orvosi Hetilap 2008; 149(51): 2413 doi: 10.1556/oh.2008.28519
|
| 43 |
Diego Garcia-Compean, Joel Omar Jaquez-Quintana, Jose Alberto Gonzalez-Gonzalez, Hector Maldonado-Garza. Liver cirrhosis and diabetes: Risk factors, pathophysiology, clinical implications and management. World Journal of Gastroenterology 2009; 15(3): 280-288 doi: 10.3748/wjg.15.280
|
| 44 |
Diego García-Compean, Joel Omar Jaquez-Quintana, Héctor Maldonado-Garza. Hepatogenous diabetes. Current views of an ancient problem. Annals of Hepatology 2009; 8(1): 13 doi: 10.1016/S1665-2681(19)31805-8
|
| 45 |
Huseyin Korkmaz, Recep Kesli, Barıs Onder Pamuk, Suleyman Hilmi Ipekci, Yuksel Terzi, Levent Kebapcilar. Assessment of Evidence for Positive Association and Seroprevalence of Hepatitis B and C in Diabetic Patients in a Developing Country. Journal of Investigative Medicine 2015; 63(2): 251 doi: 10.1097/JIM.0000000000000126
|
| 46 |
Abdel-Rahman El-Zayadi. Hepatic steatosis: A benign disease or a silent killer. World Journal of Gastroenterology 2008; 14(26): 4120-4126 doi: 10.3748/wjg.14.4120
|
| 47 |
José A Del Campo, Manuel Romero-Gómez. Steatosis and insulin resistance in hepatitis C: A way out for the virus?. World Journal of Gastroenterology 2009; 15(40): 5014-5019 doi: 10.3748/wjg.15.5014
|
| 48 |
Preetam Nath, Anil C. Anand. Hepatogenous Diabetes: A Primer. Journal of Clinical and Experimental Hepatology 2021; 11(5): 603 doi: 10.1016/j.jceh.2021.04.012
|
| 49 |
Nadhya Allia, Poernomo Boedi Setiawan, Soebagijo Adi Soelistijo. CORRELATION BETWEEN HCV RNA VIRAL LOAD AND HOMA-IR IN CHRONIC HEPATITIS C PATIENTS. Current Internal Medicine Research and Practice Surabaya Journal 2021; 2(2): 29 doi: 10.20473/cimrj.v2i2.26537
|
| 50 |
Nicoleta V. Leach, Eleonora Dronca, Stefan C. Vesa, Dorel P. Sampelean, Elena C. Craciun, Monica Lupsor, Dana Crisan, Roxana Tarau, Razvan Rusu, Ioana Para, Mircea Grigorescu. Serum homocysteine levels, oxidative stress and cardiovascular risk in non-alcoholic steatohepatitis. European Journal of Internal Medicine 2014; 25(8): 762 doi: 10.1016/j.ejim.2014.09.007
|
| 51 |
Dibya L. Praharaj, Anil C. Anand. Nutrition in Viral Hepatitis. Current Hepatology Reports 2023; 22(1): 9 doi: 10.1007/s11901-023-00596-6
|
| 52 |
James R. Sowers. The Cardiometabolic Syndrome and Liver Disease. Journal of the CardioMetabolic Syndrome 2008; 3(1): 5 doi: 10.1111/j.1559-4572.2008.08248.x
|
| 53 |
Yasuji Arase, Fumitaka Suzuki, Yoshiyuki Suzuki, Norio Akuta, Masahiro Kobayashi, Yusuke Kawamura, Hiromi Yatsuji, Hitomi Sezaki, Tetsuya Hosaka, Miharu Hirakawa, Satoshi Saito, Kenji Ikeda, Mariko Kobayashi, Hiromitsu Kumada, Tetsuro Kobayashi. Losartan reduces the onset of type 2 diabetes in hypertensive Japanese patients with chronic hepatitis C . Journal of Medical Virology 2009; 81(9): 1584 doi: 10.1002/jmv.21572
|
| 54 |
Yoshinao Kobayashi, Motoh Iwasa, Hirohide Miyachi, Ryosuke Sugimoto, Hideaki Tanaka, Rumi Mifuji-Moroka, Naoki Fujita, Yasuhiro Sumida, Yoshiyuki Takei. Effect of Iron-Mediated Oxidative Stress on Insulin Resistance Through the Forkhead Box-Containing Protein O Subfamily-1 (FOXO-1) Pathway in Chronic Hepatitis C. International Journal of Clinical Medicine 2013; 4(01): 10 doi: 10.4236/ijcm.2013.41004
|
| 55 |
Diego García-Compeán, Joel O. Jáquez-Quintana, José A. González-González, Fernando J. Lavalle-González, Jesús Z. Villarreal-Pérez, Hector J. Maldonado-Garza. La diabetes en la cirrosis hepática. Gastroenterología y Hepatología 2013; 36(7): 473 doi: 10.1016/j.gastrohep.2013.01.012
|
| 56 |
Agnieszka Badora-Rybicka, Marek Waluga, Joanna Musialik, Grzegorz Boryczka, Paulina Będkowska, Marek Hartleb. Can laboratory parameters be predictive factors for treatment effectiveness
of patients suffering from viral hepatitis C?. Annales Academiae Medicae Silesiensis 2015; 69: 91 doi: 10.18794/aams/29127
|
| 57 |
Alicia Oca�a‑Mondrag�n, Jos� Mata‑Mar�n, Mario Uriarte‑L�pez, Carolina Bekker‑M�ndez, Enrique Alcal�‑Mart�nez, Rosa Ribas‑Aparicio, Luis Uribe‑Nogu�z, Dulce Rodr�guez‑Galindo, Mar�a Mart�nez‑Rodr�guez. Effect of branched‑chain amino acid supplementation on insulin resistance and quality of life in chronic hepatitis C patients. Biomedical Reports 2017; doi: 10.3892/br.2017.1012
|
| 58 |
James Yue Zhang, Curtis Cooper, Mary-Anne Doyle. Association between hepatitis C antiviral treatment and diabetes mellitus: A case series. Official Journal of the Association of Medical Microbiology and Infectious Disease Canada 2020; 5(2): 104 doi: 10.3138/jammi-2019-0007
|
| 59 |
Yingling Jiang, Lihua Zhou. Association between chronic hepatitis C infection and metabolic syndrome: A meta-analysis. Nutrition Clinique et Métabolisme 2022; 36(3): 197 doi: 10.1016/j.nupar.2022.03.002
|
| 60 |
Beatriz R. Oliveira, Otávio Magalhães, Tania W. Furlanetto, Marcello C. Bertoluci. Increased insulin resistance and hyperinsulinemia in patients with type 2 diabetes and chronic hepatitis C. Diabetes Research and Clinical Practice 2008; 79(2): e11 doi: 10.1016/j.diabres.2007.08.003
|
| 61 |
Joel Omar Jáquez Quintana, Diego García-Compean, Jose Alberto González González, Jesús Zacarías Villarreal Pérez, Fernando Javier Lavalle González, Linda Elsa Muñoz Espinosa, Pedro López Hernández, Erick Reyes Cabello, Edgar Redondo Villarreal, Ricardo Flores Rendón, Héctor Maldonado Garza. The impact of diabetes mellitus in mortality of patients with compensated liver cirrhosis-a prospective study. Annals of Hepatology 2011; 10(1): 56 doi: 10.1016/S1665-2681(19)31588-1
|
| 62 |
Loraine Kay D. Cabral, Luca Grisetti, Muhammad Yogi Pratama, Claudio Tiribelli, Devis Pascut. Biomarkers for the Detection and Management of Hepatocellular Carcinoma in Patients Treated with Direct-Acting Antivirals. Cancers 2022; 14(11): 2700 doi: 10.3390/cancers14112700
|
| 63 |
Ebtissam Zakaria, Tarek Fayad, Mary N. Rizk, Nashwa S. Ghanem, Maisa Kamal. Association between insulin resistance, metabolic syndrome, and duration of hepatitis C in Egyptian patients. The Egyptian Journal of Internal Medicine 2013; 25(4): 213 doi: 10.4103/1110-7782.124987
|
| 64 |
Ugur Unluturk, Tomris Erbas. Tryptophan Metabolism: Implications for Biological Processes, Health and Disease. Molecular and Integrative Toxicology 2015; : 147 doi: 10.1007/978-3-319-15630-9_7
|
| 65 |
Adit Singhal, Aniruddh Agrawal, Jun Ling. Regulation of insulin resistance and type II diabetes by hepatitis C virus infection: A driver function of circulating miRNAs. Journal of Cellular and Molecular Medicine 2018; 22(4): 2071 doi: 10.1111/jcmm.13553
|
| 66 |
Meltem Sezis Demirci, Huseyin Toz, Filiz Yılmaz, Muhittin Ertilav, Gulay Asci, Mehmet Ozkahya, Aysin Zeytinoglu, Deniz Nart, Ercan Ok. Risk factors and consequences of post‐transplant diabetes mellitus. Clinical Transplantation 2010; 24(5) doi: 10.1111/j.1399-0012.2010.01247.x
|
| 67 |
Dina Ragab, Melissa Laird, Darragh Duffy, Armanda Casrouge, Rasha Mamdouh, Amal Abass, Dina El. Shenawy, Abdelhadi M. Shebl, Wagdi F. Elkashef, Khaled R. Zalata, Mostafa Kamal, Gamal Esmat, Philippe Bonnard, Arnaud Fontanet, Mona Rafik, Matthew L. Albert. CXCL10 antagonism and plasma sDPPIV correlate with increasing liver disease in chronic HCV genotype 4 infected patients. Cytokine 2013; 63(2): 105 doi: 10.1016/j.cyto.2013.04.016
|
| 68 |
Ming-Ling Chang. Metabolic alterations and hepatitis C: From bench to bedside. World Journal of Gastroenterology 2016; 22(4): 1461-1476 doi: 10.3748/wjg.v22.i4.1461
|
| 69 |
Fatih Güzelbulut, Mesut Sezikli, Züleyha Akkan Çetinkaya, Selvinaz Özkara, Can Gönen, Ayşe Oya Kurdaş Övünç. A Lower Serum Gamma-Glutamyltransferase Level Does Not Predict a Sustained Virological Response in Patients with Chronic Hepatitis C Genotype 1. Gut and Liver 2013; 7(1): 74 doi: 10.5009/gnl.2013.7.1.74
|
| 70 |
Fahed Parvaiz, Sobia Manzoor, Jawed Iqbal, Steven McRae, Farrakh Javed, Qazi Laeeque Ahmed, Gulam Waris. Hepatitis C virus nonstructural protein 5A favors upregulation of gluconeogenic and lipogenic gene expression leading towards insulin resistance: a metabolic syndrome. Archives of Virology 2014; 159(5): 1017 doi: 10.1007/s00705-013-1892-3
|
| 71 |
Mariana V. Machado, Helena Cortez-Pinto. Insulin resistance and steatosis in chronic hepatitis C. Annals of Hepatology 2009; 8: S67 doi: 10.1016/S1665-2681(19)31829-0
|
| 72 |
Diego García-Compeán, José Alberto González-González, Fernando Javier Lavalle-González, Emmanuel Irineo González-Moreno, Jesús Zacarías Villarreal-Pérez, Héctor Jesús Maldonado-Garza. Hepatogenous diabetes: Is it a neglected condition in chronic liver disease?. World Journal of Gastroenterology 2016; 22(10): 2869-2874 doi: 10.3748/wjg.v22.i10.2869
|
| 73 |
Tao Huang, Guohui Ding, Yixue Li, Lei Liu, Eugene Tan, Hongyue Dai, Qi Liu, Zhidong Tu, Lu Xie. Dysfunctional gene/protein networks in hepatitis C virus-induced hepatocellular cirrhosis and carcinoma. Proceedings of the First ACM International Conference on Bioinformatics and Computational Biology 2010; : 502 doi: 10.1145/1854776.1854873
|
| 74 |
Sreedhara H G, Rudramuneswara Swamy B P, Mahantesh S, Vijayakumara H G, Nagaraj E R. PREVALENCE OF HEPATITIS C VIRUS INFECTION IN NON INSULIN DEPENDENT DIABETIC PATIENTS (NIDDM). Journal of Evidence Based Medicine and Healthcare 2015; 2(34): 5269 doi: 10.18410/jebmh/2015/733
|
| 75 |
Vanessa Gutierrez de ANDRADE, Fábio da Silva YAMASHIRO, Cássio Vieira OLIVEIRA, Alecsandro MOREIRA, Fernanda Cristina WINCKLER, Giovanni Faria SILVA. INSULIN RESISTANCE REDUCTION AFTER SUSTAINED VIROLOGICAL RESPONSE WITH DIRECT ACTING ANTIVIRAL:NOT EVERY POPULATION IMPROVES. Arquivos de Gastroenterologia 2018; 55(3): 274 doi: 10.1590/s0004-2803.201800000-69
|
| 76 |
Riccardo NEVOLA, Carlo ACIERNO, Pia C. PAFUNDI, Luigi E. ADINOLFI. Chronic hepatitis C infection induces cardiovascular disease and type 2 diabetes: mechanisms and management. Minerva Medica 2021; 112(2) doi: 10.23736/S0026-4806.20.07129-3
|
| 77 |
Tao Huang, Junjie Wang, Yu-Dong Cai, Hanry Yu, Kuo-Chen Chou, John E. Tavis. Hepatitis C Virus Network Based Classification of Hepatocellular Cirrhosis and Carcinoma. PLoS ONE 2012; 7(4): e34460 doi: 10.1371/journal.pone.0034460
|
| 78 |
Riccardo Nevola, Luca Rinaldi, Letizia Zeni, Ciro Romano, Aldo Marrone, Raffaele Galiero, Pia Clara Pafundi, Carlo Acierno, Erica Vetrano, Luigi Elio Adinolfi. Changes in clinical scenarios, management, and perspectives of patients with chronic hepatitis C after viral clearance by direct-acting antivirals. Expert Review of Gastroenterology & Hepatology 2021; 15(6): 643 doi: 10.1080/17474124.2021.1877136
|
| 79 |
Yasmin Saad, Amal Ahmed, Doa’a A. Saleh, Wahid Doss. Adipokines and insulin resistance, predictors of response to therapy in Egyptian patients with chronic hepatitis C virus genotype 4. European Journal of Gastroenterology & Hepatology 2013; 25(8): 920 doi: 10.1097/MEG.0b013e32835f2726
|
| 80 |
Chiara Giordanino, Marco Sacco, Simone Ceretto, Antonina Smedile, Alessia Ciancio, Giuseppe Cariti, Tiziano De Blasi, Antonio Picciotto, Simona Marenco, Alessandro Grasso, Mario Pirisi, Carlo Smirne, Cosimo Colletta, Antonio Traverso, Dario Mazzucco, Giovannino Ciccone, Daniele Simondi, Mario Rizzetto, Giorgio Saracco. Durability of the response to peginterferon-α2b and ribavirin in patients with chronic hepatitis C. European Journal of Gastroenterology & Hepatology 2014; 26(1): 52 doi: 10.1097/MEG.0b013e328362dc99
|
| 81 |
G. F. Oxenkrug, W. A. Turski, W. Zgrajka, J. V. Weinstock, P. Summergrad. Tryptophan-Kynurenine Metabolism and Insulin Resistance in Hepatitis C Patients. Hepatitis Research and Treatment 2013; 2013: 1 doi: 10.1155/2013/149247
|
| 82 |
B de Chassey, V Navratil, L Tafforeau, M S Hiet, A Aublin‐Gex, S Agaugué, G Meiffren, F Pradezynski, B F Faria, T Chantier, M Le Breton, J Pellet, N Davoust, P E Mangeot, A Chaboud, F Penin, Y Jacob, P O Vidalain, M Vidal, P André, C Rabourdin‐Combe, V Lotteau. Hepatitis C virus infection protein network. Molecular Systems Biology 2008; 4(1) doi: 10.1038/msb.2008.66
|
| 83 |
Koen Vercauteren, Ahmed Atef Mesalam, Geert Leroux-Roels, Philip Meuleman. Impact of lipids and lipoproteins on hepatitis C virus infection and virus neutralization. World Journal of Gastroenterology 2014; 20(43): 15975-15991 doi: 10.3748/wjg.v20.i43.15975
|
| 84 |
Hesham M. Elgouhari, Claudia O. Zein, Ibrahim Hanouneh, Ariel E. Feldstein, Nizar N. Zein. Diabetes Mellitus Is Associated with Impaired Response to Antiviral Therapy in Chronic Hepatitis C Infection. Digestive Diseases and Sciences 2009; 54(12): 2699 doi: 10.1007/s10620-008-0683-2
|
| 85 |
Hee Jae Jung, Young Seok Kim, Sang Gyune Kim, Yun Nah Lee, Soung Won Jeong, Jae Young Jang, Sae Hwan Lee, Hong Soo Kim, Boo Sung Kim. The impact of pegylated interferon and ribavirin combination treatment on lipid metabolism and insulin resistance in chronic hepatitis C patients. Clinical and Molecular Hepatology 2014; 20(1): 38 doi: 10.3350/cmh.2014.20.1.38
|
| 86 |
Telma E. Silva, Marcelo F. Ronsoni, Leonardo L. Schiavon. Challenges in diagnosing and monitoring diabetes in patients with chronic liver diseases. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2018; 12(3): 431 doi: 10.1016/j.dsx.2017.12.013
|
| 87 |
Said M. Hashemi, David van der Poorten, Francisco Barrera, Priyanka Bandara, Ora Lux, James Kench, Jacob George. Oxidative stress is closely associated with insulin resistance in genotypes 1 and 3 chronic hepatitis C. Hepatology International 2013; 7(2): 516 doi: 10.1007/s12072-012-9400-5
|
| 88 |
Ntethelelo Sibiya, Nomusa Mzimela, Bonisiwe Mbatha, Phikelelani Ngubane, Andile Khathi. The Insights on Why Diabetes Prevalence May Increase Amid or Post
COVID-19 Pandemic. Current Diabetes Reviews 2023; 19(4) doi: 10.2174/1573399818666220411122345
|
| 89 |
Gregory F. Oxenkrug. Targeting the Broadly Pathogenic Kynurenine Pathway. 2015; : 169 doi: 10.1007/978-3-319-11870-3_13
|
| 90 |
Maria Ferrara, Anya Umlauf, Chelsea Sanders, Jonathan M. Meyer, John Allen McCutchan, Nichole Duarte, Joseph Hampton Atkinson, Igor Grant, Ronald J. Ellis. The concomitant use of second-generation antipsychotics and long-term antiretroviral therapy may be associated with increased cardiovascular risk. Psychiatry Research 2014; 218(1-2): 201 doi: 10.1016/j.psychres.2014.04.015
|
| 91 |
Jingkun Liu, Linbang Wang, Wenjun Wang, Yaping Li, Xiaoli Jia, Song Zhai, Juan Shi, Shuangsuo Dang. Application of network construction to estimate functional changes to insulin receptor substrates 1 and 2 in Huh7 cells following infection with the hepatitis C virus. Molecular Medicine Reports 2016; 14(3): 2379 doi: 10.3892/mmr.2016.5527
|
| 92 |
Rita Moretti, Mauro Giuffrè, Nicola Merli, Paola Caruso, Stefano Di Bella, Claudio Tiribelli, Lory Saveria Crocè. Hepatitis C Virus-Related Central and Peripheral Nervous System Disorders. Brain Sciences 2021; 11(12): 1569 doi: 10.3390/brainsci11121569
|
| 93 |
Delphine Degré, Thierry Gustot, Ariane Gerkens, Nathalie Boon, Jonas Schreiber, Antonia Lepida, Thomas Sersté, Pierre Deltenre, Jacques Devière, Eric Trépo, Christophe Moreno. Insulin resistance is associated with esophageal varices in alcoholic liver disease patients. European Journal of Gastroenterology & Hepatology 2016; 28(7): 792 doi: 10.1097/MEG.0000000000000627
|
| 94 |
Sadaf Badar, Sadaf Badar, Bushra Khubaib, Bushra Khubaib, Muhammad Idrees, Muhammad Idrees, Abrar Hussain, Abrar Hussain, Zunaira Awan, Zunaira Awan, Sadia Butt, Sadia Butt, Samia Afzal, Samia Afzal, Madeeha Akram, Madeeha Akram, Zareen Fatima, Zareen Fatima, Mahwish Aftab, Mahwish Aftab, Sana Saleem, Sana Saleem, Sara Munir, Sara Munir, Bisma Rauff, Bisma Rauff, Mahrukh Naudhani, Mahrukh Naudhani, Ali Liaquat, Liaquat Ali, Muhammaad Ali, Muhammaad Ali, Irshad-ul Rehman, Irshadul Rehman. Association of Hepatitis C Virus With Insulin Resistance: Evidences From Animal Studies and Clinical Studie. Hepatitis Monthly 2012; 12(1): 11 doi: 10.5812/hepatmon.4295
|
| 95 |
Hany Aly Hussein, Ahmed Samir Allam, Ahmed Samir Abdel Moaty. Evaluation of Glycated Haemoglobin (HbA1c) Level in Type 2 Diabetic Chronic HCV Non-cirrhotic Treatment-Naïve Egyptian Patients Eradicated with Sofosbuvir Plus Daclatasvir. Current Diabetes Reviews 2020; 16(2): 165 doi: 10.2174/1573399815666190531091128
|
| 96 |
Ahmed Nagaty, Ekram W. Abd El-Wahab, Tatsuo Kanda. Real-life results of sofosbuvir based therapy in chronic hepatitis C -naïve and -experienced patients in Egypt. PLOS ONE 2017; 12(10): e0184654 doi: 10.1371/journal.pone.0184654
|
| 97 |
Manuel Romero-Gómez, Conrado M. Fernández-Rodríguez, Raúl J. Andrade, Moisés Diago, Sonia Alonso, Ramón Planas, Ricard Solá, José A. Pons, Javier Salmerón, Rafael Barcena, Ramón Perez, Isabel Carmona, Santiago Durán. Effect of sustained virological response to treatment on the incidence of abnormal glucose values in chronic hepatitis C. Journal of Hepatology 2008; 48(5): 721 doi: 10.1016/j.jhep.2007.11.022
|
| 98 |
Kathleen E. Corey, Nirali Shah, Joseph Misdraji, Barham K. Abu Dayyeh, Hui Zheng, Atul K. Bhan, Raymond T. Chung. The effect of angiotensin‐blocking agents on liver fibrosis in patients with hepatitis C. Liver International 2009; 29(5): 748 doi: 10.1111/j.1478-3231.2009.01973.x
|
| 99 |
Diego García-Compeán, José Alberto González-González, Fernando Javier Lavalle-González, Emmanuel Irineo González-Moreno, Jesús Zacarías Villarreal-Pérez, Héctor J. Maldonado-Garza. Current Concepts in Diabetes Mellitus and Chronic Liver Disease: Clinical Outcomes, Hepatitis C Virus Association, and Therapy. Digestive Diseases and Sciences 2016; 61(2): 371 doi: 10.1007/s10620-015-3907-2
|
| 100 |
Sadaf Badar, Sadaf Badar, Bushra Khubaib, Bushra Khubaib, Muhammad Idrees, Muhammad Idrees, Abrar Hussain, Abrar Hussain, Zunaira Awan, Zunaira Awan, Sadia Butt, Sadia Butt, Samia Afzal, Samia Afzal, Madeeha Akram, Madeeha Akram, Zareen Fatima, Zareen Fatima, Mahwish Aftab, Mahwish Aftab, Sana Saleem, Sana Saleem, Sara Munir, Sara Munir, Bisma Rauff, Bisma Rauff, Mahrukh Naudhani, Mahrukh Naudhani, Ali Liaquat, Liaquat Ali, Muhammaad Ali, Muhammaad Ali, Irshad-ul Rehman, Irshadul Rehman. Association of Hepatitis C Virus With Insulin Resistance: Evidences From Animal Studies and Clinical Studie. Hepatitis Monthly 2012; 12(1): 11 doi: 10.5812/hepatmon.4295
|
| 101 |
Kamila Wójcik, Elżbieta Jabłonowska, Aleksandra Omulecka, Anna Piekarska. Insulin resistance, adipokine profile and hepatic expression of <italic>SOCS-3</italic> gene in chronic hepatitis C. World Journal of Gastroenterology 2014; 20(30): 10449-10456 doi: 10.3748/wjg.v20.i30.10449
|
| 102 |
Manuel Romero-Gómez. Pathogenesis and natural course of hepatic steatosis and insulin resistance in patients with hepatitis C. Current Hepatitis Reports 2008; 7(3): 113 doi: 10.1007/s11901-008-0024-0
|
| 103 |
Shereen Abdel Alem, Aisha Elsharkawy, Rabab Fouad, Eman Adel, Zeinab Abdellatif, Sherief Musa, Ahmed Nagy, Muhammad S. Hussein, Ayman Yosry, Gamal Esmat. Improvement of glycemic state among responders to Sofosbuvir‐based treatment regimens: Single center experience. Journal of Medical Virology 2017; 89(12): 2181 doi: 10.1002/jmv.24897
|
| 104 |
Luigi E. Adinolfi, Salvatore Petta, Anna L. Fracanzani, Riccardo Nevola, Carmine Coppola, Vincenzo Narciso, Luca Rinaldi, Vincenza Calvaruso, Pia Clara Pafundi, Rosa Lombardi, Laura Staiano, Vito Di Marco, Antonio Solano, Aldo Marrone, Mariarosaria Saturnino, Francesca Rini, Barbara Guerrera, Graziano Troina, Mauro Giordano, Antonio Craxì, Ferdinando C. Sasso. Reduced incidence of type 2 diabetes in patients with chronic hepatitis C virus infection cleared by direct‐acting antiviral therapy: A prospective study. Diabetes, Obesity and Metabolism 2020; 22(12): 2408 doi: 10.1111/dom.14168
|
| 105 |
Woo Jin Chung. Chronic Hepatitis C and Insulin Resistance. The Korean Journal of Gastroenterology 2012; 59(4): 268 doi: 10.4166/kjg.2012.59.4.268
|
| 106 |
Heather L. Stevenson, Netanya S. Utay. Hepatic steatosis in HCV-infected persons in the direct-acting antiviral era. Tropical Diseases, Travel Medicine and Vaccines 2016; 2(1) doi: 10.1186/s40794-016-0038-5
|
| 107 |
Armanda Casrouge, Jérémie Decalf, Mina Ahloulay, Cyril Lababidi, Hala Mansour, Anaïs Vallet-Pichard, Vincent Mallet, Estelle Mottez, James Mapes, Arnaud Fontanet, Stanislas Pol, Matthew L. Albert. Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV. Journal of Clinical Investigation 2011; 121(1): 308 doi: 10.1172/JCI40594
|
| 108 |
Yasuji Arase, Fumitaka Suzuki, Yoshiyuki Suzuki, Norio Akuta, Masahiro Kobayashi, Yusuke Kawamura, Hiromi Yatsuji, Hitomi Sezaki, Tetsuya Hosaka, Miharu Hirakawa, Kenji Ikeda, Hiromitsu Kumada. Sustained virological response reduces incidence of onset of type 2 diabetes in chronic hepatitis C†. Hepatology 2009; 49(3): 739 doi: 10.1002/hep.22703
|
| 109 |
Wen Ma, Wentao Wu, Weixing Wen, Fengshuo Xu, Didi Han, Jun Lyu, Yuli Huang. Association of NAFLD with cardiovascular disease and all-cause mortality: a large-scale prospective cohort study based on UK Biobank. Therapeutic Advances in Chronic Disease 2022; 13 doi: 10.1177/20406223221122478
|
| 110 |
Maribel Rodriguez‐Torres, Sugantha Govindarajan, Moises Diago, Thomas Morgan, Bhupinderjit Anand, Karl Barange, Frank Suter, Amy Lin, Gregory Hooper, Mitchell Shiffman. Hepatic steatosis in patients with chronic hepatitis C virus genotype 2 or 3 does not affect viral response in patients treated with peginterferon α‐2a (40KD) (PEGASYS®) plus ribavirin (COPEGUS®) for 16 or 24 weeks. Liver International 2009; 29(2): 237 doi: 10.1111/j.1478-3231.2008.01859.x
|
| 111 |
Inas Kostandi, Magy Bahgat, Naglaa Zayed, Laila Rashed. Assessment of Insulin Resistance and Insulin Growth Factor-1 in Egyptian Patients with Chronic Hepatitis C. Open Journal of Endocrine and Metabolic Diseases 2011; 1(01): 1 doi: 10.4236/ojemd.2011.11001
|
| 112 |
Hala O. El-Mesallamy, Nadia M. Hamdy, Hanan H. Rizk, Abdel-Rahman El-Zayadi. Apelin Serum Level in Egyptian Patients with Chronic Hepatitis C. Mediators of Inflammation 2011; 2011: 1 doi: 10.1155/2011/703031
|
| 113 |
Silvia Mirandola, David Bowman, Mahmood M Hussain, Alfredo Alberti. Hepatic steatosis in hepatitis C is a storage disease due to HCV interaction with microsomal triglyceride transfer protein (MTP). Nutrition & Metabolism 2010; 7(1) doi: 10.1186/1743-7075-7-13
|
| 114 |
Qin-qin Wang, Jie Zhang, Jin-song Hu, Hao-tai Chen, Li Du, Li-qin Wu, Yao-zhong Ding, Sheng-he Xiong, Xin-cheng Huang, Yin-hong Zhang, Yong-sheng Liu. Rapid detection of hepatitis C virus RNA by a reverse transcription loop-mediated isothermal amplification assay. FEMS Immunology & Medical Microbiology 2011; 63(1): 144 doi: 10.1111/j.1574-695X.2011.00828.x
|
| 115 |
Harold Ariel Muñoz Díaz, Adán José Lúquez Mindiola, Andrés José Gómez Aldana. Fisiopatología de la hepatitis C y diabetes mellitus. Hacia la cura de dos epidemias en el siglo XXI. Revista Colombiana de Gastroenterología 2019; 34(3): 277 doi: 10.22516/25007440.322
|
| 116 |
Y.‐Y. Zheng, L.‐F. Wang, X.‐H. Fan, C.‐H. Wu, N. Huo, H.‐Y. Lu, X.‐Y. Xu, L. Wei. Association of suppressor of cytokine signalling 3 polymorphisms with insulin resistance in patients with chronic hepatitis C. Journal of Viral Hepatitis 2013; 20(4): 273 doi: 10.1111/j.1365-2893.2012.01644.x
|
| 117 |
C. H. Y. Chan, R. D. Hansen, R. S. Gilliver, B. E. Jones. Sustained virological response following chronic hepatitis C treatment is associated with improvement in insulin resistance. Internal Medicine Journal 2013; 43(6): 656 doi: 10.1111/imj.12136
|
| 118 |
Décio Passos Sampaio Péres, Hugo Cheinquer, Fernando Herz Wolf, Nelson Cheinquer, Maicon Falavigna, Luciana Dornelles Sampaio Péres. Prevalence of insulin resistance in chronic hepatitis C genotype 1 and 3 patients. Annals of Hepatology 2013; 12(6): 871 doi: 10.1016/S1665-2681(19)31291-8
|